New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:54 EDTPLXProtalix's agreement for UPLYSO with Brazil's Ministry of Health approved
Protalix BioTherapeutics announced that the Brazilian National Institute of Industrial Property has approved the company's previously-announced supply and technology transfer agreement with Fundação Oswaldo Cruz, an arm of the Brazilian Ministry of Health for UPLYSO (alfataliglicerase). The company has already completed the first shipment of the drug to Brazil under the agreement.
News For PLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 16, 2015
09:19 EDTPLXOn The Fly: Pre-market Movers
HIGHER: Nexvet Biopharma (NVET), up 16.8% after NV-01 study meets primary endpoint... Protalix BioTherapeutics (PLX), up 4.8% after announcing that it will conduct a Phase III clinical trial for PRX-102... Array Biopharma (ARRY), up 4.3% after announcing a commercialization collaboration with Pierre Fabre... Perrigo (PRGO), up 2.1% after being upgraded to Buy from Neutral at UBS. DOWN AFTER EARNINGS: Dillard's (DDS), down 11.7% after reporting quarterly results. ALSO LOWER: Clovis Oncology (CLVS), down 71.3% after the FDA requested additional clinical data for rociletinib... KaloBios Pharmaceuticals (KBIO), down 48.9% after announcing that it will wind down its operations... Starwood Hotels (HOT), down 6.3% after announcing that Marriott (MAR) will acquire the company... Marriott is down 2.4%... Five Below (FIVE), down 3.1% after being downgraded to Hold from Buy at Deutsche Bank.
07:06 EDTPLXProtalix to conduct Phase III clinical trial for PRX-102
Subscribe for More Information
November 13, 2015
16:08 EDTPLXProtalix files $100M mixed securities shelf
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use